We are one of the world's leading providers of biophysical assays. We bring together talented scientists from diverse life science backgrounds to provide high-quality biophysical analysis services to thousands of researchers worldwide.

We are committed to developing and delivering innovative and efficient biophysical assay technologies. We offer the perfect service package for a wide range of project types and scientific questions for all researchers working or interested in protein analysis, protein- and RNA-based drug discovery or molecular interaction characterization. Learn more：high-quality biophysical analysis services

RNA interference (RNAi) has emerged as a powerful tool to investigate gene function and regulation in Drosophila, paving the way for a deeper understanding of biological processes and disease mechanisms. Our Drosophila RNAi Service is designed to empower researchers with the most reliable and efficient RNAi techniques, enabling them to unravel the complexities of gene function in their studies.

Learn more：Drosophila RNAi

Methylation-Based Biological Age and Cancer Risk Changes in DNA methylation levels with age, and it has been widely studied as a well-known biomarker of aging. A number of DNA methylation age clocks have appeared and been used, and when the age predicted by the methylation clock is greater than the actual age, it is considered to have "age acceleration", which is also called the biological measure of aging.

Research suggests a correlation between aging and cancer as well. Predicted ages obtained by DNA methylation analysis are greater than actual ages, indicating age acceleration, and these phenomena may also be strongly associated with cancer risk. By analyzing the age acceleration of DNA methylation to discover their association with increased cancer risk or shorter survival, it could help to understand specific relationship between the aging process and cancer development, developing DNA methylation as a tool for predicting cancer risk.

Learn more：Lymphoma research